Innovation to Impact: Therapeutics, Diagnostics, Vaccines
Our researchers work across the full pipeline, from early-stage discovery through to clinical trials, regulatory navigation and delivery.
With expertise in diagnostics, therapeutics, vaccines, and human challenge models, we harness disruptive technologies and global partnerships to develop accessible, effective solutions.
Our research centres and units collaborate with industry, academia and policymakers to ensure breakthroughs move beyond the lab and into real-world use.
Whether tackling antimicrobial resistance or accelerating pandemic tools, we focus on impact, improving lives through research that reaches those who need it most.
Centres of Excellence
Our specialist Centres, Units and Institutes lead research into emerging and re-emerging diseases. By uniting clinical, scientific and operational expertise, they drive innovation in diagnostics, treatment and disease elimination, working with global partners to reduce burden and improve health outcomes.
Meet the team developing therapeutics, diagnostics and vaccines through world-class research and practical solutions.
Dr Kayla Barnes
Senior Lecturer and Associate Professor, Dr Barnes is a genomics researcher based at the Malawi-Liverpool Wellcome Trust whose work spans viral pathogen surveillance and single-cell studies to understand vaccine performance in low-income countries.
Dr Ezekiel Boro
Ezekiel Boro is the Head of Innovation Capacity Strengthening (ICS) in the Enterprise and Innovation Unit at the Liverpool School of Tropical Medicine.
Professor Nick Casewell
Professor Casewell leads research on snake venom variation and the development of new therapeutics, including monoclonal antibodies and small molecule inhibitors, to improve snakebite treatment efficacy.
Featured projects
TOCSINS drug trials
TOCSINS (Trial of Oral Combination Therapies for Snakebite Envenoming) is a groundbreaking clinical trial led by the Centre for Snakebite Research and Interventions (CSRI) at LSTM.
MMVSola
A free tool that predicts how new malaria drugs will work in patients
